Josh Hardman

editor and founder of Psychedelic Alpha

Josh Hardman on KCRW

The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.

MDMA therapy for PTSD treatment? FDA panel says no

The panel was concerned about the strength of the evidence, allegations of participant abuse, and ill-defined therapeutic protocols. It’s a step backwards for the psychedelic movement.

from Press Play with Madeleine Brand

More from KCRW

This week, cognitive scientist and professor of psychology at Yale University Lori Santos explains that negative emotions are very much part of the human experience and essential to…

from Life Examined

Statistics can be intimidating. But before you decide to begin a treatment you should ask what the expected benefit will be to you.

from Second Opinion

The cleanup is underway in Altadena and Pacific Palisades, and local organizations are educating immigrant day laborers on how to stay safe.

from KCRW Features

It’s hard to tell, but we have no way to know for sure.

from Second Opinion

St. John’s Community Health is meeting its undocumented patients’ needs for at-home care through its new Health Care Without Fear program.

from KCRW Features

Author, poet, and philosopher David Whyte reflects on the power of words and explores why accepting and celebrating the human condition is such a gift.

from Life Examined

Nearly 2 in 5 LGBTQ+ youth considered suicide in the last year. They could lose access to a federally-funded suicide hotline under possible budget cuts.

from KCRW Features

AI is increasingly being used to collect and process clinical information. Whether this is a good thing depends on who you ask.

from Second Opinion

This week, journalist and author of The Explorers Gene:Why We Seek Big Challenges, New Flavors, and the Blank Spots on the Map,” Alex Hutchinson tackles something athletes and sports…

from Life Examined